Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-analysis of Randomized Control Trials.

Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE, Andrews CN, Leontiadis GI, Moayyedi P.

Am J Gastroenterol. 2018 Oct 18. doi: 10.1038/s41395-018-0258-6. [Epub ahead of print] Review.

PMID:
30337705
2.

Response to Marlicz et al.

Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2018 May;113(5):781. doi: 10.1038/s41395-018-0034-7. Epub 2018 Mar 9. No abstract available.

PMID:
29523865
3.

Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia.

Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2017 Sep;112(9):1484. doi: 10.1038/ajg.2017.238. Epub 2017 Aug 1. No abstract available.

PMID:
28762378
4.

ACG and CAG Clinical Guideline: Management of Dyspepsia.

Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2017 Jul;112(7):988-1013. doi: 10.1038/ajg.2017.154. Epub 2017 Jun 20. Review.

PMID:
28631728
5.

Wearable Microsystem for Minimally Invasive, Pseudo-Continuous Blood Glucose Monitoring: The e-Mosquito.

Wang G, Poscente MD, Park SS, Andrews CN, Yadid-Pecht O, Mintchev MP.

IEEE Trans Biomed Circuits Syst. 2017 Oct;11(5):979-987. doi: 10.1109/TBCAS.2017.2669440. Epub 2017 May 25.

PMID:
28574366
6.

Varicella-Zoster Virus Gastritis: Case Report and Review of the Literature.

Nohr EW, Itani DM, Andrews CN, Kelly MM.

Int J Surg Pathol. 2017 Aug;25(5):449-452. doi: 10.1177/1066896917696751. Epub 2017 Mar 1. Review.

PMID:
28381144
7.

Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.

Tse Y, Armstrong D, Andrews CN, Bitton A, Bressler B, Marshall J, Liu LW.

Can J Gastroenterol Hepatol. 2017;2017:8612189. doi: 10.1155/2017/8612189. Epub 2017 Feb 8.

8.

Constipation in a 40-year-old woman.

Panda H, Andrews CN.

CMAJ. 2016 Mar 1;188(4):277-8. doi: 10.1503/cmaj.150761. Epub 2015 Dec 14. No abstract available.

9.

Targeting extra-oral bitter taste receptors modulates gastrointestinal motility with effects on satiation.

Avau B, Rotondo A, Thijs T, Andrews CN, Janssen P, Tack J, Depoortere I.

Sci Rep. 2015 Nov 6;5:15985. doi: 10.1038/srep15985.

10.

Prospective evaluation of gastric neurostimulation for diabetic gastroparesis in Canada.

Panda H, Mitchell P, Curley M, Buresi M, Wilsack L, Andrews CN.

Can J Gastroenterol Hepatol. 2015 May;29(4):198-202.

11.

Vision testing is additive to the sideline assessment of sports-related concussion.

Marinides Z, Galetta KM, Andrews CN, Wilson JA, Herman DC, Robinson CD, Smith MS, Bentley BC, Galetta SL, Balcer LJ, Clugston JR.

Neurol Clin Pract. 2015 Feb;5(1):25-34. doi: 10.1212/CPJ.0000000000000060.

12.

Transcutaneous intraluminal impedance measurement for minimally invasive monitoring of gastric motility: validation in acute canine models.

Poscente MD, Wang G, Filip D, Ninova P, Muench G, Yadid-Pecht O, Mintchev MP, Andrews CN.

Gastroenterol Res Pract. 2014;2014:691532. doi: 10.1155/2014/691532. Epub 2014 Dec 9.

13.

Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Bashashati M, Hejazi RA, Andrews CN, Storr MA.

Can J Gastroenterol Hepatol. 2014 Jun;28(6):335-41. Epub 2014 Apr 9.

14.

Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher".

Nasser Y, Bashashati M, Andrews CN.

Neurogastroenterol Motil. 2014 Apr;26(4):447-54. doi: 10.1111/nmo.12329.

PMID:
24641009
15.

Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.

Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN.

Inflamm Bowel Dis. 2014 Mar;20(3):472-80. doi: 10.1097/01.MIB.0000440982.79036.d6.

PMID:
24407485
16.

Real-time gastric motility monitoring using transcutaneous intraluminal impedance measurements (TIIM).

Poscente MD, Wang G, Filip D, Ninova P, Yadid-Pecht O, Andrews CN, Mintchev MP.

Physiol Meas. 2014 Feb;35(2):217-29. doi: 10.1088/0967-3334/35/2/217. Epub 2014 Jan 7.

PMID:
24398539
17.

Luminal lipoma: the "pot-of-gold" sign.

Chen Y, Andrews CN.

Gastrointest Endosc. 2014 Jan;79(1):167; discussion 167. doi: 10.1016/j.gie.2013.08.036. Epub 2013 Oct 7. No abstract available.

PMID:
24112591
18.

Lichen planus is an uncommon cause of nonspecific proximal esophageal inflammation.

Linton MS, Zhao L, Gui X, Storr M, Andrews CN.

Gut Liver. 2013 Jul;7(4):401-5. doi: 10.5009/gnl.2013.7.4.401. Epub 2013 Jun 11.

19.

Diabetic gastroparesis.

Vanormelingen C, Tack J, Andrews CN.

Br Med Bull. 2013;105:213-30. doi: 10.1093/bmb/ldt003. Epub 2013 Jan 29. Review.

PMID:
23363458
20.

Suture marker lesion detection in the colon by self-stabilizing and unmodified capsule endoscopes: pilot study in acute canine models.

Filip D, Yadid-Pecht O, Muench G, Mintchev MP, Andrews CN.

Gastrointest Endosc. 2013 Feb;77(2):272-9. doi: 10.1016/j.gie.2012.10.016.

PMID:
23317692
21.

The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study.

Syed AA, Andrews CN, Shaffer E, Urbanski SJ, Beck P, Storr M.

Aliment Pharmacol Ther. 2012 Nov;36(10):950-8. doi: 10.1111/apt.12053. Epub 2012 Sep 20.

22.

Colometer: a real-time quality feedback system for screening colonoscopy.

Filip D, Gao X, Angulo-Rodríguez L, Mintchev MP, Devlin SM, Rostom A, Rosen W, Andrews CN.

World J Gastroenterol. 2012 Aug 28;18(32):4270-7. doi: 10.3748/wjg.v18.i32.4270.

23.

Evaluation of endoscopist and pathologist factors affecting the incidence of microscopic colitis.

Andrews CN, Beck PL, Wilsack L, Urbanski SJ, Storr M.

Can J Gastroenterol. 2012 Aug;26(8):515-20.

24.

Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population.

Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ.

Can J Gastroenterol. 2012 Jul;26(7):452-6.

25.

Unsedated peroral wireless pH capsule placement vs. standard pH testing: a randomized study and cost analysis.

Andrews CN, Sadowski DC, Lazarescu A, Williams C, Neshev E, Storr M, Au F, Heitman SJ.

BMC Gastroenterol. 2012 May 31;12:58. doi: 10.1186/1471-230X-12-58.

26.

Functional studies of the gastrointestinal tract in adult surgical clinics: when do they help?

Bashashati M, Andrews CN.

Int J Surg. 2012;10(6):280-4. doi: 10.1016/j.ijsu.2012.04.017. Epub 2012 May 3.

27.

Technical note: Evaluation of tined endoscopically placed mucosal leads for temporary gastric neurostimulation.

Mintchev P, Arriagada A, Mintchev MP, Andrews CN.

Neuromodulation. 2012 May-Jun;15(3):219-22; discussion 222-3. doi: 10.1111/j.1525-1403.2012.00428.x. Epub 2012 Feb 28.

PMID:
22372579
28.

Cytokines and irritable bowel syndrome: where do we stand?

Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NE, Sharkey KA, Storr MA.

Cytokine. 2012 Feb;57(2):201-9. doi: 10.1016/j.cyto.2011.11.019. Epub 2011 Dec 16. Review.

PMID:
22178716
29.

The pathophysiology of chronic constipation.

Andrews CN, Storr M.

Can J Gastroenterol. 2011 Oct;25 Suppl B:16B-21B. Review.

30.

Self-stabilizing colonic capsule endoscopy: pilot study of acute canine models.

Filip D, Yadid-Pecht O, Andrews CN, Mintchev MP.

IEEE Trans Med Imaging. 2011 Dec;30(12):2115-25. doi: 10.1109/TMI.2011.2163165. Epub 2011 Jul 29.

PMID:
21803680
31.

Design, implementation and testing of an implantable impedance-based feedback-controlled neural gastric stimulator.

Arriagada AJ, Jurkov AS, Neshev E, Muench G, Andrews CN, Mintchev MP.

Physiol Meas. 2011 Aug;32(8):1103-15. doi: 10.1088/0967-3334/32/8/007. Epub 2011 Jun 21.

PMID:
21693794
32.

Gastrointestinal symptoms in Parkinson disease: clinical aspects and management.

Salat-Foix D, Andrews CN, Meddings J, Suchowersky O.

Can J Neurol Sci. 2011 Jul;38(4):557-64. Review.

PMID:
21672695
33.

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.

Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP.

Aliment Pharmacol Ther. 2011 Aug;34(3):374-83. doi: 10.1111/j.1365-2036.2011.04732.x. Epub 2011 Jun 14.

34.

The association of coeliac disease and microscopic colitis: a large population-based study.

Stewart M, Andrews CN, Urbanski S, Beck PL, Storr M.

Aliment Pharmacol Ther. 2011 Jun;33(12):1340-9. doi: 10.1111/j.1365-2036.2011.04666.x. Epub 2011 Apr 24.

35.

Percutaneous endoscopically assisted transenteric full-thickness gastric biopsy: initial experience in humans.

Andrews CN, Mintchev P, Neshev E, Fraser HF, Storr M, Bathe OF, Urbanski SJ.

Gastrointest Endosc. 2011 May;73(5):949-54. doi: 10.1016/j.gie.2010.12.037. Epub 2011 Mar 9.

PMID:
21392758
36.

Comparative gastric motility study of Enterra ™ Therapy and neural gastric electrical stimulation in an acute canine model.

Arriagada A, Jurkov AS, Neshev E, Muench G, Mintchev MP, Andrews CN.

Neurogastroenterol Motil. 2011 Mar;23(3):271-8, e122. doi: 10.1111/j.1365-2982.2010.01636.x. Epub 2010 Dec 5.

PMID:
21129125
37.

A novel method of full-thickness gastric biopsy via a percutaneous, endoscopically assisted, transenteric approach.

Fraser H, Neshev E, Storr M, Urbanski SJ, Andrews CN.

Gastrointest Endosc. 2010 Apr;71(4):831-4. doi: 10.1016/j.gie.2009.11.048.

PMID:
20363426
38.

Microscopic colitis -- a common cause of diarrhoea in older adults.

Williams JJ, Beck PL, Andrews CN, Hogan DB, Storr MA.

Age Ageing. 2010 Mar;39(2):162-8. doi: 10.1093/ageing/afp243. Epub 2010 Jan 11. Review.

PMID:
20065357
39.

Microscopic colitis: a review for the surgical endoscopist.

Datta I, Brar SS, Andrews CN, Dupre M, Ball CG, Buie WD, Beck PL.

Can J Surg. 2009 Oct;52(5):E167-72. Review.

40.

Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors.

Fichna J, Schicho R, Andrews CN, Bashashati M, Klompus M, McKay DM, Sharkey KA, Zjawiony JK, Janecka A, Storr MA.

Neurogastroenterol Motil. 2009 Dec;21(12):1326-e128. doi: 10.1111/j.1365-2982.2009.01369.x. Epub 2009 Jul 23.

PMID:
19650775
41.

Pneumatic dilation for achalasia: a centimetre outside the comfort zone?

Andrews CN.

Can J Gastroenterol. 2009 May;23(5):340-1. No abstract available.

42.

Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use.

Law JK, Andrews CN, Enns R.

Gastrointest Endosc. 2009 Jan;69(1):3-9. doi: 10.1016/j.gie.2008.04.053. Epub 2008 Aug 20.

PMID:
18718583
43.

The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.

Storr MA, Yüce B, Andrews CN, Sharkey KA.

Neurogastroenterol Motil. 2008 Aug;20(8):857-68. doi: 10.1111/j.1365-2982.2008.01175.x. Review.

PMID:
18710476
44.

Medical management of irritable bowel syndrome in 2008: current and future directions.

Storr M, Andrews CN.

Can J Gastroenterol. 2008 Aug;22(8):673-5. No abstract available.

45.

Evaluation of lower functional gut disorders.

Andrews CN, Storr M.

Can J Gastroenterol. 2008 Jul;22(7):614-6. Review. No abstract available.

46.

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.

Bharucha AE, Charkoudian N, Andrews CN, Camilleri M, Sletten D, Zinsmeister AR, Low PA.

Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R874-80. doi: 10.1152/ajpregu.00153.2008. Epub 2008 Jul 2.

47.

Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.

Andrews CN, John Gill M, Urbanski SJ, Stewart D, Perini R, Beck P.

Am J Gastroenterol. 2008 Jul;103(7):1762-9. doi: 10.1111/j.1572-0241.2008.01794.x. Epub 2008 Jun 28.

PMID:
18557717
48.

Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects.

Bharucha AE, Skaar T, Andrews CN, Camilleri M, Philips S, Seide B, Burton D, Baxter K, Zinsmeister AR.

Neurogastroenterol Motil. 2008 Aug;20(8):891-9. doi: 10.1111/j.1365-2982.2008.01124.x. Epub 2008 Apr 16.

49.

Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.

Bharucha AE, Seide B, Guan Z, Andrews CN, Zinsmeister AR.

Neurogastroenterol Motil. 2008 Jun;20(6):643-8. doi: 10.1111/j.1365-2982.2008.01089.x. Epub 2008 Feb 25.

PMID:
18312543
50.

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.

Aerssens J, Camilleri M, Talloen W, Thielemans L, Göhlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):194-205. doi: 10.1016/j.cgh.2007.11.012.

Supplemental Content

Loading ...
Support Center